On Tuesday, the eye care company Alcon Plc (NYSE:ALC) agreed to acquire STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the implantable collamer lens (ICL). The acquisition includes the EVO ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alcon has announced a definitive agreement to acquire STAAR Surgical Company, maker of the EVO Implantable Collamer Lens (ICL) for vision correction in patients with moderate to high myopia, including ...

Vision Care delivered Q4 sales of $1.2 billion, up 7% year on year, as the segment benefited from innovation and pricing actions. Contact Lens revenue increased 4% to $683 million despite tough ...

The global need for eye care is increasing as populations age and more people are diagnosed with cataracts, glaucoma, and other vision-related conditions. Many of these indications require medical ...

TORONTO--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of TOTAL30 ® for Astigmatism and DAILIES ...

Alcon stock reflects the medical technology group’s position in global eye care, with steady demand for surgical and vision care products shaping the long-term story for investors. Alcon stock mirrors ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alcon Agrees to Acquire STAAR Surgical “With the number of high myopes rising globally, the acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those ...

Please provide your email address to receive an email when new articles are posted on . The acquisition is expected to close in 6 to 12 months. The transaction will include STAAR’s family of EVO ICLs.